Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.2B | 17.2B | 16.7B | 17.4B |
Cost of revenue | 8.1B | 8.5B | 7.9B | 7.6B |
Gross profit | 9.1B | 8.6B | 8.9B | 9.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 767M | 705M | 652M | 597M |
Other operating expenses | 639M | 790M | 730M | 778M |
Operating income | 7.5B | 7.0B | 7.3B | 8.3B |
Non operating interest income | ||||
Income | 764M | 33M | 1.0B | 636M |
Expense | -93M | — | 84M | 47M |
Other income expense | — | — | — | — |
Pretax income | 8.4B | 7.7B | 8.3B | 8.7B |
Tax provision | 2.0B | 2.3B | 2.5B | 2.6B |
Net income | 6.4B | 5.4B | 5.8B | 6.2B |
Basic EPS | — | 62.4 | 66.6 | 71.1 |
Diluted EPS | — | 62.0 | 66.2 | 70.7 |
Basic average shares | — | 86.8M | 86.7M | 86.7M |
Diluted average shares | — | 87.3M | 87.3M | 87.2M |
EBITDA | 8.5B | 7.1B | 8.6B | 9.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |